Clinical Trial Update: Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 trial update suggests hydroxychloroquine sulfate may alleviate persistent proteinuria in primary IgA nephropathy, though status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary IgA Nephropathy | Phase 4 | Status: UNKNOWN